Laws, G. A., Kemp, R. A., Probiotics and health: understanding probiotic trials, New Zealand Medical Journal, 2019. Vol 132 No 1498.
Norton, S. E*.,Ward-Hartstonge,K. A*., McCall, J. L., Leman, J. K. H.,Taylor, E. H.,Munro, F., Black, M. A.,Fazekas de St. Groth, B., McGuire,H. M. andKemp, R. (2019)A. High-Dimensional Mass Cytometric Analysis Reveals an Increase in Effector Regulatory T Cells as a Distinguishing Feature of Colorectal Tumors. Journal of immunology, available online February 6th2019.
Leman JKH, Sandford SK, Rhodes JL, Kemp RA. Multiparametric analysis of colorectal cancer immune responses. 2018. World J Gastroenterol. Jul 21;24(27):2995-3005. doi: 10.3748/wjg.v24.i27.2995
Ailin Lepletier, Viviana P Lutzky, Deepak Mittal, Kimberley Stannard, Thomas S Watkins, Champa N Ratnatunga, Corey Smith, Helen M McGuire, Roslyn A Kemp, Pamela Mukhopadhyay, Nicola Waddell, Mark J Smyth, William C Dougall, John J Miles. The immune checkpoint CD96 defines a distinct lymphocyte phenotype & is highly expressed on tumor‐infiltrating T cells. 2018. Immunol Cell Biol. First published: 17 September 2018. https://doi.org/10.1111/imcb.12205
Norton S, Kemp R, Computational Analysis of High Dimensional Mass Cytometry Data from Clinical Tissue Samples. Methods Mol Biol. 2018;1770 (In Press)
Taylor ES, McCall JL, Shen S, Girardin A, Munro F, Black MA, Ward-Hartstonge KA, Kemp RA. Prognostic roles for IL-2-producing and CD69+ T cell subsets in colorectal cancer patients. Int J Cancer2018 Oct 15;143(8):2008-2016. doi: 10.1002/ijc.31598
Ward-Hartstonge KA and Kemp RA. Regulatory T-cell heterogeneity and the cancer immune response. Clinical & Translational Immunology (2017) 6, e154; doi:10.1038/cti.2017.43 Published online 15 September 2017
Ward-Hartstonge, K.A., McCall, J.L., McCulloch, T.R. et al. Inclusion of BLIMP-1+ effector regulatory T cells improves the Immunoscore in a cohort of New Zealand colorectal cancer patients - a pilot studyCancer Immunol Immunother (2017) 66: 515. https://doi.org/10.1007/s00262-016-1951-1